Gonadotropin-Releasing Hormone Induces Apoptosis of Prostate Cancer Cells
Authors:
Open Access
- 15 August 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (16) , 5736-5744
Abstract
A standard therapy used today for prostate cancer is androgen ablation by gonadotropin-releasing hormone analogs (GnRH-a). Although most patients respond to androgen ablation as an initial systemic therapy, nearly all cases will develop androgen resistance, the management of which is still a major challenge. Here, we report that GnRH-a can directly induce apoptosis of the androgen-independent prostate cancer-derived DU145 and PC3 cell lines. Using specific inhibitors, we found that the apoptotic effect of GnRH-a is mediated by c-Jun NH2-terminal kinase (JNK) and inhibited by the phosphatidylinositol 3′-kinase (PI3K)-protein kinase B (PKB) pathway. Indeed, in DU145 cells, GnRH-a activates the JNK cascade in a c-Src- and MLK3-dependent manner but does not involve protein kinase C and epidermal growth factor receptor. Concomitantly, GnRH-a reduces the activity of the PI3K-PKB pathway, which results in the dephosphorylation of PKB mainly in the nucleus. The reduction of PKB activity releases PKB-induced inhibition of MLK3 and thus further stimulates JNK activity and accelerates the apoptotic effect of GnRH-a. Interestingly, extracellular signal-regulated kinase is also activated by GnRH-a, and this occurs via a pathway that involves matrix metalloproteinases and epidermal growth factor receptor, but its activation does not affect JNK activation and the GnRH-a-induced apoptosis. Our results support a potential use of GnRH-a for the treatment of advanced prostate cancer and suggest that the outcome of this treatment can be amplified by using PI3K-PKB inhibitors.Keywords
This publication has 49 references indexed in Scilit:
- Akt2 Negatively Regulates Assembly of the POSH-MLK-JNK Signaling ComplexJournal of Biological Chemistry, 2003
- AKT2 Inhibition of Cisplatin-induced JNK/p38 and Bax Activation by Phosphorylation of ASK1Journal of Biological Chemistry, 2003
- Negative Regulation of Mixed Lineage Kinase 3 by Protein Kinase B/AKT Leads to Cell SurvivalJournal of Biological Chemistry, 2003
- Activation of MAPK Cascades by GnRH: ERK and Jun N-Terminal Kinase Are Involved in Basal and GnRH-Stimulated Activity of the Glycoprotein Hormone LH -Subunit PromoterEndocrinology, 2002
- Androgen receptor expression in androgen‐independent prostate cancer cell linesThe Prostate, 2001
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-IIEuropean Journal of Cancer, 1997
- Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptorsNature, 1996
- Growth inhibition of human prostate tumor cells by an agonist of gonadotrophin‐releasing hormoneThe Prostate, 1995
- Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaPThe Journal of Clinical Endocrinology & Metabolism, 1992